Clinical Trial Update: Treatment Outcomes for Temporomandibular Disorders (TMD) Via the Clayton Intra-aural Device (CID) Clinical Trial [Phase 1, Phase 2]

View source ↗

Summary

This document reports the results of Phase 1 and Phase 2 trials evaluating the Clayton Intra-aural Device (CID) for temporomandibular disorders, with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Temporomandibular Disorders

Drugs mentioned

• Clayton Intra-aural Device (CID)

Snippet

Sponsor: Ascentia Health, Inc. | Conditions: Temporomandibular Disorders | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2010-08-06